Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

19%

4 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (4)
Early P 1 (1)
P 1 (1)
P 2 (4)
P 3 (2)
P 4 (2)

Trial Status

Completed11
Unknown7
Recruiting3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT05253287Phase 2Completed

Growth Hormone in Decompensated Liver Cirrhosis

NCT03091374Phase 2Completed

Impact of Recombinant Human Growth Hormone on HIV Persistence

NCT05195437CompletedPrimary

Evolution of the Quality of Life of Short Statured Children Treated With Growth Hormone : Evaluation at Adult Size

NCT06037473RecruitingPrimary

The Efficacy and Safety of PEGylated GH for the Treatment of Short Stature in Chinese Children-GLOBE Reg

NCT04938466Completed

Assessment of Adherence, Quality of Life, Clinical Response and Safety of Daily and Long-Acting Growth Hormone Therapy

NCT06448195Phase 4RecruitingPrimary

Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery

NCT06103513Phase 3Unknown

Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children

NCT05144035Phase 4Recruiting

A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants

NCT04244123Completed

Web-based Adherence Information Integrated Nurse-led Monitoring Clinic

NCT03038594Phase 2Completed

Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients

NCT05660356Early Phase 1UnknownPrimary

Growth Hormone Deficiency in Mild Traumatic Brain Injury

NCT05105685Phase 1Completed

Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS

NCT03431727Unknown

Acromegaly - Before and After Treatment

NCT02782221Not ApplicableCompleted

Lipolytic Effects of GH in Human Subjects in Vivo

NCT03878992Not ApplicableUnknown

Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle

NCT02987868Not ApplicableCompletedPrimary

Effects of an Amino Acid-Based hGH Secretagogue on Triiodythyronine

NCT03033121Phase 3CompletedPrimary

Three-times-weekly Versus Daily Growth Hormone (GH) Treatment in naïve GH-deficient Children

NCT03203356CompletedPrimary

Adrenal Function in GHD Children

NCT03005561Not ApplicableUnknownPrimary

Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment

NCT02326610Phase 2Unknown

Early hGH Treatment of SGA Infants to Prevent Irreversible Neurologic and Psychological Damage and Sequelae

Scroll to load more

Research Network

Activity Timeline